Non-metabolic active signaling pathways can also contribute to the resistance of CML LSCs to TKIs, including the Sonic hedgehog, Wnt/βcatenin, PI3K/AKT, and JAK/STAT. The gene discussed is AKT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.